These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26012290)

  • 21. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-year follow-up study of allergen-induced in vitro cytokine and signalling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy.
    Nieminen K; Laaksonen K; Savolainen J
    Int Arch Allergy Immunol; 2009; 150(4):370-6. PubMed ID: 19571569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy.
    Kopp MV; Hamelmann E; Bendiks M; Zielen S; Kamin W; Bergmann KC; Klein C; Wahn U;
    Pediatr Allergy Immunol; 2013 Aug; 24(5):427-33. PubMed ID: 23799935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy evaluation of standardized dust mite allergen specific immunotherapy to patients of allergic rhinitis].
    Song W; Lin X; Chai R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(5):300-2. PubMed ID: 25185281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites.
    Song Y; Long J; Wang T; Xie J; Wang M; Tan G
    J Laryngol Otol; 2018 Mar; 132(3):230-235. PubMed ID: 29374499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
    Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
    J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of sublingual immunotherapy with Dermatophagoides farina drops in monosensitized and polysensitized children with allergic rhinitis and asthma].
    Xing QB; Chen S; Chen B; Li HF; Chen LL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(3):204-208. PubMed ID: 29871223
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment.
    Martín-Muñoz MF; Pineda F; Muiños T; Fontan M; Nevot S; Bosque M; Jurado Palomo J; Torredemer A; Valdesoiro L; Martinez Cañavate AM; Pedemonte Marco C;
    Allergol Immunopathol (Madr); 2013; 41(1):4-10. PubMed ID: 22321665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.
    Đurić-Filipović I; Caminati M; Kostić G; Filipović Đ; Živković Z
    World J Pediatr; 2016 Aug; 12(3):283-290. PubMed ID: 27351563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical observation of flupentixol and melitracen combined with specific immunotherapy for treatment of allergic rhinitis patients with anxiety and depression].
    Yi ZG; Yang XH; Ren JJ; Peng WH; Liang QL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):34-37. PubMed ID: 29774682
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical efficacy and costs of the three-year specific allergen immunotherapy--retrospective study].
    Targowski T; Jahnz-Rózyk K; Przekora P; Kucharczyk A; Owczarek W
    Pol Merkur Lekarski; 2011 Aug; 31(182):106-10. PubMed ID: 21936348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of the efficacy of specific immunotherapy of allergic rhinitis after withdrawal of dust mites drops in about one year].
    Qiu T; Tao ZZ; Xu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):722-725. PubMed ID: 29771022
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?
    Cox LS
    JAMA; 2017 Feb; 317(6):591-593. PubMed ID: 28196239
    [No Abstract]   [Full Text] [Related]  

  • 35. [Analysis of the compliance and effectiveness of the allergen specific immunotherapy in patients with allergic rhinitis].
    Weng YC; Gu DS; Zeng DQ; Zhang L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):542-545. PubMed ID: 29871065
    [No Abstract]   [Full Text] [Related]  

  • 36. Specific immunotherapy in allergic rhinitis.
    Mortuaire G; Michel J; Papon JF; Malard O; Ebbo D; Crampette L; Jankowski R; Coste A; Serrano E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep; 134(4):253-258. PubMed ID: 28684084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of specific immunotherapy on the psychological health level and quality of life in patients with allergic rhinitis].
    Guo JF; Liu P; Wu HQ; Lin LL; Liu Z; Xiong BB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):712-714. PubMed ID: 29771019
    [No Abstract]   [Full Text] [Related]  

  • 38. The efficacy and safety of sublingual immunotherapy in children and adult patients with allergic rhinitis.
    Lin X; Lin H; Wei X; Huang Q
    Allergol Immunopathol (Madr); 2017; 45(5):457-462. PubMed ID: 28237130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergen immunotherapy.
    Frew AJ
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S306-13. PubMed ID: 20176266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety of specific immunotherapy for patients allergic to house-dust mites and pollen in relation to the development of neoplasia and autoimmune disease: a long-term, observational case-control study.
    Bozek A; Kozłowska R; Jarzab J
    Int Arch Allergy Immunol; 2014; 163(4):307-12. PubMed ID: 24776522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.